Compare DeFi (DEFI) vs Enzyme (MLN) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
DeFi vs Enzyme — how do they compare? DeFi trades at Rp13.17 (market cap Rp19,87M, Rp6,62M 24h volume), while Enzyme trades at Rp30,212 (market cap Rp134,13M, Rp104,56M 24h volume). The key difference: Enzyme is far larger — about 6.8× DeFi's market cap, and DeFi's supply is capped (1,7B / 3B DEFI (59%)) while Enzyme's keeps growing. Which is the better fit depends on your goals — on Pluang, investors hold DeFi for 7 Days and Enzyme for 29 Days on average.
| DEFI | MLN | |
|---|---|---|
Market Cap | Rp19,87M | Rp134,13M |
Volume (24h) | Rp6,62M | Rp104,56M |
Circulating Supply | 1,7B / 3B DEFI (59%) | 3,3M MLN |
Typical Hold Time | 7 Days | 29 Days |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
DEFI token shows limited market activity with a modest market cap of Rp19.87M and 59% circulating supply. The token faces headwinds from broader crypto market volatility and ETF closures affecting investor sentiment. Technical indicators suggest cautious trading with a 7-day average hold time indicating short-term positioning. Recent news highlights regulatory developments and institutional crypto demand shifts.
Overall outlook remains cautious with opportunities in DeFi ecosystem growth but significant risks from market volatility and regulatory uncertainty. Key risks include low liquidity, ETF market instability, and potential regulatory headwinds that could impact token performance.
Enzyme (MLN) shows limited market activity with a market cap of Rp134,13M and circulating supply of 3,3jt tokens. The asset demonstrates a relatively short hold time of 29 days, suggesting active trading patterns. Current technical positioning requires updated price data for comprehensive analysis. Recent ecosystem developments appear limited based on available information.
Overall outlook remains cautious due to limited market data and ecosystem activity. Key opportunities include potential protocol upgrades and increased adoption, while major risks involve low liquidity and market volatility. Investors should monitor on-chain metrics and exchange listings for improved visibility.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About DeFi
DeFi is a Web3 antivirus and SocialFi super app that has been protecting users from scams and bad actors since its launch in July 2020. By 2023, the platform grew to over 5 million users, tracking $25 billion in user funds. Its DeFi Antivirus has already secured over $1.2 billion from potential losses, while providing leading portfolio-tracking and security solutions.
Read more on DEFI →About Enzyme
Enzyme is an easy-to-use on-chain asset management system that enables access to digital assets and DeFi from one simple, unified app. It provides a front-to-back execution and order management system, which provides fully automated reporting, risk management, administration, governance and operations.
Read more on MLN →
